Close

ADVANcing For Clinical Evidence Now Launched In Singapore

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...

Recently in Singapore, ADVANcing Clinical Evidence in Infectious Diseases- ADVANCE-ID was formally introduced by its director, Prof. David Paterson, at the ADVANCE-ID Launch Symposium. More than 30 hospitals in Asia work together as part of the ADVANCE-ID network to undertake clinical research on infectious diseases.

To share knowledge about how nations can prevent and treat infectious diseases, over 100 thought leaders and experts from 17 different countries gathered at the NUSS Kent Ridge Guild House. The discussion focused on the threat posed by antimicrobial resistance in an era of dwindling supplies of new antibiotics. Panel talks and breakout sessions on research goals for physicians in ADVANCE-ID were also part of the two-day conference.

Prof. Kenneth Mak, Director of Medical Services at the Singapore Ministry of Health, gave the symposium’s opening remarks. Prof. Mak highlighted antimicrobial resistance (AMR) as a pandemic that spreads slowly but can have a significant impact on healthcare systems and communities in his opening remarks. He said he was confident that the ADVANCE-ID initiative will lead to fruitful collaborations and exchanges, just as it will encourage high-caliber clinical research to produce workable solutions and fresh approaches to the AMR problem, inform upstream AMR-related policy strategies, and ultimately enhance health outcomes.

ADVANCE-ID was founded in March 2022 with funding from the National Centre for Infectious Diseases, NTU Lee Kong Chian School of Medicine, NUS Saw Swee Hock School of Public Health, NUS Yong Loo Lin School of Medicine, Duke-NUS Medical School, and the Wellcome Trust. This network’s implementation will also have an involvement of the Singapore Clinical Research Institute.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back